Influx Healthtech Share Price

Influx Healthtech Limited was originally incorporated on September 28 2020 as a Private Limited Company as Influx Healthtech Private Limited with the Registrar of Companies Central Registration Centre. Company converted from a Private Limited to Public Limited and the name of Company was changed to Influx Healthtech Limited and a Fresh Certificate of Incorporation upon the conversion was issued on May 23 2022 by the Registrar of Companies Mumbai.Influx Healthtech Limited is a a Mumbaibased healthcare productfocused company that has carved a niche in manufacturing Soft Gelatin Tablets Capsules Liquid Orals Oral Powders Liquid fill capsules Effervescent tablets Nutra Pallets Protein Bars Cookies Jellies/ Gummies External preparations like Creams Gels Ointments External Oils Soaps etc. for the Nutraceuticals Cosmetics Ayurvedic / Herbal Veterinary Feed Supplements and Homecare segment. Influx was founded by Mr. Munir Abdul Ganee Chandniwala and Ms. Shirin Munir Ahmed Chandniwala of becoming market leading third party manufacturer who is specializes in the nutraceuticals cosmetics veterinary food supplements herbal remedies and homecare industries.The Company is majorly involved in the manufacturing of Dietary/Nutritional Supplements Gym/Sports Supplements Veterinary Feeds Liquid fill capsules Ayurvedic products and homecare products for small and medium marketing and distribution brands. It specialized in manufacturing of dietary and nutritional supplements and which supports their clients during the product development phase and manufacturing of products which can further be processed into distribution and marketing by different brands.The Company operates three manufacturing plants located in Thane Maharashtra which are certified with GMP HACCP ISO 22000 and Halal and are equipped with advanced machinery a quality control department and a skilled workforce. It works as a Contract Development and Manufacturing Organization CDMO which is a thirdparty manufacturer. It specialize in a diverse products across several segments including Dietary/Nutritional Supplements Cosmetics Ayurvedic / Herbal Veterinary Feed Supplements and Homecare segment. This includes the production of Active Pharmaceutical Ingredients APIs and the manufacturing of finished dosage forms such as tablets capsules and injectables.The Company is planning an IPO aggregating by issuance of 6000000 Equity Shares comprising a Fresh Issue of 4632000 Equity Shares and 1368000 Equity Shares through Offer for Sale..

Listing date: 25 Jun, 2025
Chairperson Name: Munir Abdul Ganee Chandniwala